Gene · 838
Papers1,806
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,806
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and verification of a prognostic model for colon cancer on pyroptosis-related genes. | Front Genet | 2022 | 36246625 | PubTator, text mining | PubMed |
| Gut bacterial extracellular vesicles: important players in regulating intestinal microenvironment. | Gut Microbes | 2022 | 36242585 | PubTator, text mining | PubMed |
| A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer. | Transl Cancer Res | 2022 | 36237236 | PubTator, text mining | PubMed |
| CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy. | Hum Vaccin Immunother | 2022 | 36222759 | PubTator, text mining | PubMed |
| Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma. | Front Immunol | 2022 | 36211429 | PubTator, text mining | PubMed |
| Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. | Mil Med Res | 2022 | 36209190 | PubTator, text mining | PubMed |
| The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma. | Front Cell Dev Biol | 2022 | 36204682 | PubTator, text mining | PubMed |
| Bulk and Single-Cell Transcriptome Analyses Revealed That the Pyroptosis of Glioma-Associated Macrophages Participates in Tumor Progression and Immunosuppression. | Oxid Med Cell Longev | 2022 | 36199426 | PubTator, text mining | PubMed |
| Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature. | Open Biol | 2022 | 36196535 | PubTator, text mining | PubMed |
| Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. | Nat Commun | 2022 | 36192482 | PubTator, text mining | PubMed |
| Human neutrophil IL1β directs intestinal epithelial cell extrusion during Salmonella infection. | PLoS Pathog | 2022 | 36191054 | PubTator, text mining | PubMed |
| A potential new pathway for heparin treatment of sepsis-induced lung injury: inhibition of pulmonary endothelial cell pyroptosis by blocking hMGB1-LPS-induced caspase-11 activation. | Front Cell Infect Microbiol | 2022 | 36189354 | PubTator, text mining | PubMed |
| Pyroptosis in development, inflammation and disease. | Front Immunol | 2022 | 36189207 | PubTator, text mining | PubMed |
| Bibliometric analysis of global research trends on pyroptosis in lung disease. | Front Immunol | 2022 | 36177039 | PubTator, text mining | PubMed |
| A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma. | BMC Med Genomics | 2022 | 36163033 | PubTator, text mining | PubMed |
| Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis. | Aging (Albany NY) | 2022 | 36152052 | PubTator, text mining | PubMed |
| IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort. | Front Immunol | 2022 | 36148243 | PubTator, text mining | PubMed |
| Pyroptosis and Its Role in the Modulation of Cancer Progression and Antitumor Immunity. | Int J Mol Sci | 2022 | 36142404 | PubTator, text mining | PubMed |
| Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. | Cancers (Basel) | 2022 | 36139540 | PubTator, text mining | PubMed |
| A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease. | Cells | 2022 | 36139421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/838/papers?page=20